Functional role of KLF10 in multiple disease processes

BioFactors

Volumn 36, Issue 1, 2010, Pages 8-18

  Subramaniam, Malayannan ^a   Hawse, John R ^a   Rajamannan, Nalini M ^b   Ingle, James N ^c   Spelsberg, Thomas C ^a  

^a MAYO GRADUATE SCHOOL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c MAYO CLINIC   (United States)

Author keywords

Apoptosis; Bone; Cancer; Differentiation; Estrogen; Heart; Immune system; KLF10; Kr ppel family; Smads; TGF ; TGF inducible early gene; TIEG1

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; EPIDERMAL GROWTH FACTOR; KRUPPEL LIKE FACTOR; KRUPPEL LIKE FACTOR 10; SMAD2 PROTEIN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

APOPTOSIS; BONE DISEASE; BREAST CANCER; CARCINOGENESIS; CARCINOMA CELL; CELL PROLIFERATION; CONNECTIVE TISSUE DISEASE; DISEASE COURSE; DISEASE MARKER; DNA SEQUENCE; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE REPRESSION; GENE TARGETING; GENETIC CONSERVATION; GENETIC TRANSCRIPTION; HEART DISEASE; HEART VENTRICLE HYPERTROPHY; HUMAN; HUMAN VERSUS ANIMAL COMPARISON; IMMUNE SYSTEM; NONHUMAN; OSTEOBLAST; OSTEOPOROSIS; PANCREAS CARCINOMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; BONE AND BONES; BONE DISEASES, METABOLIC; BONE REMODELING; BREAST NEOPLASMS; CARDIOMEGALY; CELL DIFFERENTIATION; CELL PROLIFERATION; CONNECTIVE TISSUE DISEASES; EARLY GROWTH RESPONSE TRANSCRIPTION FACTORS; FEMALE; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MALE; MICE; MICE, KNOCKOUT; OSTEOBLASTS; PANCREATIC NEOPLASMS; PROSTATIC NEOPLASMS; SIGNAL TRANSDUCTION; SMAD PROTEINS; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA; ZINC FINGERS;

EID: 77951140067     PISSN: 09516433     EISSN: 18728081     Source Type: Journal    
DOI: 10.1002/biof.67     Document Type: Review

References (78)

1. Subramaniam, M., Harris, S. A., Oursler, M. J., Rasmussen, K., Riggs, B. L., and Spelsberg, T. C. (1995) Identification of a novel TGF-beta-regulated gene encoding a putative zinc finger protein in human osteoblasts, Nucleic Acids Res., 23, 4907-4912. (Pubitemid 3008385)
2. Blok, L. J., Grossmann, M. E., Perry, J. E., and Tindall, D. J. (1995) Characterization of an early growth response gene, which encodes a zinc finger transcription factor, potentially involved in cell cycle regulation, Mol. Endocrinol., 9, 1610-1620.
3. Fautsch, M. P., Vrabel, A., Subramaniam, M., Hefferen, T. E., Spelsberg, T. C., and Wieben, E. D. (1998) TGFbeta-inducible early gene (TIEG) also codes for early growth response alpha (EGRalpha): evidence of multiple transcripts from alternate promoters, Genomics, 51, 408-416. (Pubitemid 28413207)
4. Gunther, M., Laithier, M., and Brison, O. (2000) A set of proteins interacting with transcription factor Sp1 identified in a two-hybrid screening, Mol. Cell Biochem., 210, 131-142.
5. Fautsch, M. P., Vrabel, A., Rickard, D., Subramaniam, M., Spelsberg, T. C., and Wieben, E. D. (1998) Characterization of the mouse TGFbeta-inducible early gene (TIEG): conservation of exon and transcriptional regulatory sequences with evidence of additional transcripts, Mamm. Genome, 9, 838-842.
6. Cook, T., Gebelein, B., Belal, M., Mesa, K., and Urrutia, R. (1999) Three conserved transcriptional repressor domains are a defining feature of the TIEG subfamily of Sp1-like zinc finger proteins, J. Biol. Chem., 274, 29500-29504.
7. Hefferan, T. E., Reinholz, G. G., Rickard, D. J., Johnsen, S. A., Waters, K. M., Subramaniam, M., and Spelsberg, T. C. (2000) Overexpression of a nuclear protein, TIEG, mimics transforming growth factor-beta action in human osteoblast cells, J. Biol. Chem., 275, 20255-20259. (Pubitemid 30457597)
8. Leclerc, N., Luppen, C. A., Ho, V. V., Nagpal, S., Hacia, J. G., Smith, E., and Frenkel, B. (2004) Gene expression profiling of glucocorticoid-inhibited osteoblasts, J. Mol. Endocrinol., 33, 175-193.
9. Hofbauer, L. C., Hicok, K. C., and Khosla, S. (1998) Effects of gonadal and adrenal androgens in a novel androgen-responsive human osteoblastic cell line, J. Cell. Biochem., 71, 96-108.
10. Hawse, J. R., Subramaniam, M., Monroe, D. G., Hemmingsen, A. H., Ingle, J. N., Khosla, S., Oursler, M. J., and Spelsberg, T. C. (2008) Estrogen receptor beta isoform-specific induction of transforming growth factor beta-inducible early gene-1 in human osteoblast cells: an essential role for the activation function 1 domain, Mol. Endocrinol., 22, 1579-1595.
11. Tachibana, I., Imoto, M., Adjei, P. N., Gores, G. J., Subramaniam, M., Spelsberg, T. C., and Urrutia, R. (1997) Overexpression of the TGFbeta-regulated zinc finger encoding gene, TIEG, induces apoptosis in pancreatic epithelial cells, J. Clin. Invest., 99, 2365-2374. (Pubitemid 27227713)
12. Cook, T., Gebelein, B., Mesa, K., Mladek, A., and Urrutia, R. (1998) Molecular cloning and characterization of TIEG2 reveals a new subfamily of transforming growth factor-beta-inducible Sp1-like zinc finger-encoding genes involved in the regulation of cell growth, J. Biol. Chem., 273, 25929-25936.
13. Subramaniam, M., Hefferan, T. E., Tau, K., Peus, D., Pittelkow, M., Jalal, S., Riggs, B. L., Roche, P., and Spelsberg, T. C. (1998) Tissue, cell type, and breast cancer stage-specific expression of a TGF-beta inducible early transcription factor gene, J. Cell Biochem., 68, 226-236.
14. Kobori, N., Clifton, G. L., and Dash, P. (2002) Altered expression of novel genes in the cerebral cortex following experimental brain injury, Brain Res. Mol. Brain Res., 104, 148-158.
15. Noti, J. D., Johnson, A. K., and Dillon, J. D. (2004) The zinc finger transcription factor transforming growth factor beta-inducible early gene-1 confers myeloid-specific activation of the leukocyte integrin CD11d promoter, J. Biol. Chem., 279, 26948-26958.
16. Noti, J. D., Johnson, A. K., and Dillon, J. D. (2005) The leukocyte integrin gene CD11d is repressed by gut-enriched Kruppel-like factor 4 in myeloid cells, J. Biol. Chem., 280, 3449-3457.
17. Luo, X., Ding, L., Xu, J., and Chegini, N. (2005) Gene expression profiling of leiomyoma and myometrial smooth muscle cells in response to transforming growth factor-beta, Endocrinology, 146, 1097-1118. (Pubitemid 40289299)
18. Mitsumoto, M., Mitsumoto, A., and Demple, B. (2003) Nitric oxide-mediated upregulation of the TGF-beta-inducible early response gene-1 (TIEG1) in human fibroblasts by mRNA stabilization independent of TGFbeta, Free Radic. Biol. Med., 34, 1607-1613. (Pubitemid 36638720)
19. Yajima, S., Lammers, C. H., Lee, S. H., Hara, Y., Mizuno, K., and Mouradian, M. M. (1997) Cloning and characterization of murine glial cell-derived neurotrophic factor inducible transcription factor (MGIF), J. Neurosci., 17, 8657-8666. (Pubitemid 27481731)
20. Bender, H., Wang, Z., Schuster, N., and Krieglstein, K. (2004) TIEG1 facilitates transforming growth factor-beta-mediated apoptosis in the oligodendroglial cell line OLI-neu, J. Neurosci. Res., 75, 344-352.
21. Reinholz, M. M., An, M. W., Johnsen, S. A., Subramaniam, M., Suman, V. J., Ingle, J. N., Roche, P. C., and Spelsberg, T. C. (2004) Differential gene expression of TGF beta inducible early gene (TIEG), Smad7, Smad2 and Bard1 in normal and malignant breast tissue, Breast Cancer Res. Treat., 86, 75-88. (Pubitemid 38918898)
22. Johnsen, S. A., Subramaniam, M., Monroe, D. G., Janknecht, R., and Spelsberg, T. C. (2002) Modulation of transforming growth factor beta (TGFbeta)/Smad transcriptional responses through targeted degradation of TGF beta-inducible early gene-1 by human seven in absentia homologue, J. Biol. Chem., 277, 30754-30759.
23. Ou, X. M., Chen, K., and Shih, J. C. (2004) Dual functions of transcription factors, transforming growth factor-beta-inducible early gene (TIEG)2 and Sp3, are mediated by CACCC element and Sp1 sites of human monoamine oxidase (MAO) B gene, J. Biol. Chem., 279, 21021-21028. (Pubitemid 38656503)
24. House, C. M., Hancock, N. C., Moller, A., Cromer, B. A., Fedorov, V., Bowtell, D. D., Parker, M. W., and Polekhina, G. (2006) Elucidation of the substrate binding site of Siah ubiquitin ligase, Structure, 14, 695-701.
25. Jin, W., Di, G., Li, J., Chen, Y., Li, W., Wu, J., Cheng, T., Yao, M., and Shao, Z. (2007) TIEG1 induces apoptosis through mitochondrial apoptotic pathway and promotes apoptosis induced by homoharringtonine and velcade, FEBS Lett., 581, 3826-3832. (Pubitemid 47411513)
26. Cook, T. and Urrutia, R. (2000) TIEG proteins join the Smads as TGFbeta- regulated transcription factors that control pancreatic cell growth, Am. J. Physiol. Gastrointest. Liver Physiol., 278, G513-521. (Pubitemid 30213116)
27. Ribeiro, A., Bronk, S. F., Roberts, P. J., Urrutia, R., and Gores, G. J. (1999) The transforming growth factor beta(1)-inducible transcription factor TIEG1, mediates apoptosis through oxidative stress, Hepatology, 30, 1490-1497.
28. Wang, Z., Peters, B., Klussmann, S., Bender, H., Herb, A., and Krieglstein, K. (2004) Gene structure and evolution of Tieg3, a new member of the Tieg family of proteins, Gene, 325, 25-34.
29. Zhang, J. S., Moncrieffe, M. C., Kaczynski, J., Ellenrieder, V., Prendergast, F. G., and Urrutia, R. (2001) A conserved alpha-helical motif mediates the interaction of Sp1-like transcriptional repressors with the corepressor mSin3A, Mol. Cell. Biol., 21, 5041-5049. (Pubitemid 32656401)
30. Ellenrieder, V., Zhang, J. S., Kaczynski, J., and Urrutia, R. (2002) Signaling disrupts mSin3A binding to the Mad1-like Sin3-interacting domain of TIEG2, an Sp1-like repressor, EMBO J., 21, 2451-2460.
31. House, C. M., Frew, I. J., Huang, H. L., Wiche, G., Traficante, N., Nice, E., Catimel, B., and Bowtell, D. D. (2003) A binding motif for Siah ubiquitin ligase, Proc. Natl. Acad. Sci. USA, 100, 3101-3106. (Pubitemid 36356546)
32. Tau, K. R., Hefferan, T. E., Waters, K. M., Robinson, J. A., Subramaniam, M., Riggs, B. L., and Spelsberg, T. C. (1998) Estrogen regulation of a transforming growth factor-beta inducible early gene that inhibits deoxyribonucleic acid synthesis in human osteoblasts, Endocrinology, 139, 1346-1353. (Pubitemid 28510156)
33. Johnsen, S. A., Subramaniam, M., Janknecht, R., and Spelsberg, T. C. (2002) TGFbeta inducible early gene enhances TGFbeta/Smad-dependent transcriptional responses, Oncogene, 21, 5783-5790. (Pubitemid 35333012)
34. Johnsen, S. A., Subramaniam, M., Katagiri, T., Janknecht, R., and Spelsberg, T. C. (2002) Transcriptional regulation of Smad2 is required for enhancement of TGFbeta/Smad signaling by TGFbeta inducible early gene, J. Cell Biochem., 87, 233-241.
35. Hawse, J. R., Iwaniec, U. T., Bensamoun, S. F., Monroe, D. G., Peters, K. D., Ilharreborde, B., Rajamannan, N. M., Oursler, M. J., Turner, R. T., Spelsberg, T. C., and Subramaniam, M. (2008) TIEG-null mice display an osteopenic gender-specific phenotype, Bone, 42, 1025-1031.
36. Chalaux, E., Lopez-Rovira, T., Rosa, J. L., Pons, G., Boxer, L. M., Bartrons, R., and Ventura, F. (1999) A zinc-finger transcription factor induced by TGF-beta promotes apoptotic cell death in epithelial Mv1Lu cells, FEBS Lett., 457, 478-482. (Pubitemid 29414747)
37. Sebestyen, A., Barna, G., Nagy, K., Janosi, J., Paku, S., Kohut, E., Berczi, L., Mihalik, R., and Kopper, L. (2005) Smad signal and TGFbeta induced apoptosis in human lymphoma cells, Cytokine, 30, 228-235. (Pubitemid 40775840)
38. Jin, W., Qu, L. F., Min, P., Chen, S., Li, H., Lu, H., and Hou, Y. T. (2004) Identification of genes responsive to apoptosis in HL-60 cells, Acta Pharmacol. Sin., 25, 319-326.
39. Franke, A. G., Gubbe, C., Beier, M., and Duenker, N. (2006) Transforming growth factor-beta and bone morphogenetic proteins: cooperative players in chick and murine programmed retinal cell death, J. Comp. Neurol., 495, 263-278.
40. Johnsen, S. A., Subramaniam, M., Effenberger, K. E., and Spelsberg, T. C. (2004) The TGF-beta inducible early gene plays a central role in the anti-proliferative response to TGF-beta, Signal Transduct., 4, 29-35. (Pubitemid 39163048)
41. Subramaniam, M., Hawse, J. R., Johnsen, S. A., and Spelsberg, T. C. (2007) Role of TIEG1 in biological processes and disease states, J. Cell Biochem., 102, 539-548. (Pubitemid 47557409)
42. Yerges, L. M., Klei, L., Cauley, J. A., Roeder, K., Kammerer, C. M., Ensrud, K. E., Nestlerode, C. S., Lewis, C., Lang, T. F., Barrett-Connor, E., Moffett, S. P., Hoffman, A. R., Ferrell, R. E., Orwoll, E. S., and Zmuda, J. M., Candidate gene analysis of femoral neck trabecular and cortical volumetric bone mineral density in older men, J. Bone. Miner. Res., in press.
43. Bensamoun, S. F., Hawse, J. R., Subramaniam, M., Ilharreborde, B., Bassillais, A., Benhamou, C. L., Fraser, D. G., Oursler, M. J., Amadio, P. C., An, K. N., and Spelsberg, T. C. (2006a) TGFbeta inducible early gene-1 knockout mice display defects in bone strength and microarchitecture, Bone, 39, 1244-1251. (Pubitemid 44834502)
44. Subramaniam, M., Gorny, G., Johnsen, S. A., Monroe, D. G., Evans, G. L., Fraser, D. G., Rickard, D. J., Rasmussen, K., van Deursen, J. M., Turner, R. T., Oursler, M. J., and Spelsberg, T. C. (2005) TIEG1 null mouse-derived osteoblasts are defective in mineralization and in support of osteoclast differentiation in vitro, Mol. Cell Biol., 25, 1191-1199.
45. Haddad, O., Hawse, J. R., Subramaniam, M., Spelsberg, T. C., Bensamoun, S. F., TIEG1-null osteocytes display defects in their morphology, density and surrounding bone matrix, J. Musculoskelet. Res., DOI: 1080/10255840903081164.
46. Tsubone, T., Moran, S. L., Subramaniam, M., Amadio, P. C., Spelsberg, T. C., and An, K. N. (2006) Effect of TGF-beta inducible early gene deficiency on flexor tendon healing, J. Orthop. Res., 24, 569-575.
47. Bensamoun, S. F., Tsubone, T., Subramaniam, M., Hawse, J. R., Boumediene, E., Spelsberg, T. C., An, K. N., and Amadio, P. C. (2006b) Age-dependent changes in the mechanical properties of tail tendons in TGF-beta inducible early gene-1 knockout mice, J. Appl. Physiol., 101, 1419-1424.
48. Rajamannan, N. M., Subramaniam, M., Abraham, T. P., Vasile, V. C., Ackerman, M. J., Monroe, D. G., Chew, T. L., and Spelsberg, T. C. (2007) TGFbeta inducible early gene-1 (TIEG1) and cardiac hypertrophy: discovery and characterization of a novel signaling pathway, J. Cell. Biochem., 100, 315-325.
49. Wang, J., Xu, N., Feng, X., Hou, N., Zhang, J., Cheng, X., Chen, Y., Zhang, Y., and Yang, X. (2005) Targeted disruption of Smad4 in cardiomyocytes results in cardiac hypertrophy and heart failure, Circ. Res., 97, 821-828.
50. Cao, Z., Wara, A. K., Icli, B., Sun, X., Packard, R. R., Esen, F., Stapleton, C. J., Subramaniam, M., Kretschmer, K., Apostolou, I., von Boehmer, H., Hansson, G. K., Spelsberg, T. C., Libby, P., and Feinberg, M. W., Kruppel-like factor KLF10 targets TGF-{beta}1 to regulate CD4+CD25- T cells and T regulatory cells, J. Biol. Chem., DOI: 1074/jbc.M109.000059.
51. Venuprasad, K., Huang, H., Harada, Y., Elly, C., Subramaniam, M., Spelsberg, T., Su, J., and Liu, Y. C. (2008) The E3 ubiquitin ligase Itch regulates expression of transcription factor Foxp3 and airway inflammation by enhancing the function of transcription factor TIEG1, Nat. Immunol., 9, 245-253.
52. Eid, M. A., Kumar, M. V., Iczkowski, K. A., Bostwick, D. G., and Tindall, D. J. (1998) Expression of early growth response genes in human prostate cancer, Cancer Res., 58, 2461-2468. (Pubitemid 28252710)
53. Ellenrieder, V., Fernandez-Zapico, M. E., Urrutia, R. (2001) TGF-beta mediated signaling and transcriptional regulation in pancreatic development and cancer, Curr. Opin. Gastroenterol., 17, 434-440. (Pubitemid 32783733)
54. Ellenrieder, V. (2008) TGFbeta regulated gene expression by Smads and Sp1/KLF-like transcription factors in cancer, Anticancer Res., 28, 1531-1539.
55. Sorbello, V., Fuso, L., Sfiligoi, C., Scafoglio, C., Ponzone, R., Biglia, N., Weisz, A., Sismondi, P., and M. De Bortoli (2003) Quantitative real-time RT-PCR analysis of eight novel estrogen-regulated genes in breast cancer, Int. J. Biol. Markers, 18, 123-129. (Pubitemid 38220140)
56. Subramaniam, M., Oursler, M. J., Rasmussen, K., Riggs, B. L., and Spelsberg, T. C. (1995) TGF-beta regulation of nuclear proto-oncogenes and TGF-beta gene expression in normal human osteoblast-like cells, J. Cell. Biochem., 57, 52-61.
57. Zohrabian, V. M., Nandu, H., Gulati, N., Khitrov, G., Zhao, C., Mohan, A., Demattia, J., Braun, A., Das, K., Murali, R., and Jhanwar-Uniyal, M. (2007) Gene expression profiling of metastatic brain cancer, Oncol. Rep., 18, 321-328.
58. Hu, G., Chong, R. A., Yang, Q., Wei, Y., Blanco, M. A., Li, F., Reiss, M., Au, J. L., Haffty, B. G., and Kang, Y. (2009) MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer, Cancer Cell, 15, 9-20.
59. Jiang, L., Chen, Y., Chan, C. Y., Wang, X., Lin, L., He, M. L., Lin, M. C., Yew, D. T., Sung, J. J., Li, J. C., and Kung, H. F. (2009) Down-regulation of stathmin is required for TGF-beta inducible early gene 1 induced growth inhibition of pancreatic cancer cells, Cancer Lett., 274, 101-108.
60. Partin, J. V., Anglin, I. E., and Kyprianou, N. (2003) Quinazoline-based alpha 1-adrenoceptor antagonists induce prostate cancer cell apoptosis via TGF-beta signalling and I kappa B alpha induction, Br. J. Cancer, 88, 1615-1621.
61. Yono, M., Mane, S. M., Lin, A., Weiss, R. M., and Latifpour, J. (2008) Differential effects of diabetes induced by streptozotocin and that develops spontaneously on prostate growth in Bio Breeding (BB) rats, Life Sci., 83, 192-197.
62. Antonello, D., Moore, P. S., Zamboni, G., Falconi, M., and Scarpa, A. (2002) Absence of mutations in the transforming growth factor-beta inducible early gene 1, TIEG1, in pancreatic cancer, Cancer Lett., 183, 179-183.
63. Chen, G. G., Xu, H., Lee, J. F., Subramaniam, M., Leung, K. L., Wang, S. H., Chan, U. P., and Spelsberg, T. C. (2003) 15-hydroxy-eicosatetraenoic acid arrests growth of colorectal cancer cells via a peroxisome proliferator- activated receptor gamma-dependent pathway, Int. J. Cancer, 107, 837-843.
64. Barna, G., Sebestyen, A., Chinopoulos, C. C., Nagy, K., Mihalik, R., Paku, S., and Kopper, L. (2002) TGF beta 1 kills lymphoma cells using mitochondrial apoptotic pathway with the help of caspase-8, Anticancer Res., 22, 3867-3872. (Pubitemid 36134407)
65. Ferraro, B., Bepler, G., Sharma, S., Cantor, A., and Haura, E. B. (2005) EGR1 predicts PTEN and survival in patients with non-small-cell lung cancer, J. Clin. Oncol., 23, 1921-1926.
66. Ivanov, S. V., Ivanova, A. V., Salnikow, K., Timofeeva, O., Subramaniam, M., and Lerman, M. I. (2008) Two novel VHL targets, TGFBI (BIGH3) and its transactivator KLF10, are up-regulated in renal clear cell carcinoma and other tumors, Biochem. Biophys. Res. Commun., 370, 536-540.
67. Zhou, F. L., Zhang, W. G., Chen, G., Zhao, W. H., Cao, X. M., Chen, Y. X., Tian, W., Liu, J., and Liu, S. H. (2006) Serological identification and bioinformatics analysis of immunogenic antigens in multiple myeloma, Cancer Immunol. Immunother., 55, 910-917.
68. Chiambaretta, F., De Graeve, F., Turet, G., Marceau, G., Gain, P., Dastugue, B., Rigal, D., and Sapin, V. (2004) Cell and tissue specific expression of human Kruppel-like transcription factors in human ocular surface, Mol. Vis., 10, 901-909.
69. Duenker, N., Valenciano, A. I., Franke, A., Hernandez-Sanchez, C., Dressel, R., Behrendt, M., De Pablo, F., Krieglstein, K., and de la Rosa, E. J. (2005) Balance of pro-apoptotic transforming growth factor-beta and anti-apoptotic insulin effects in the control of cell death in the postnatal mouse retina, Eur. J. Neurosci., 22, 28-38.
70. Alme, M. N., Wibrand, K., Dagestad, G., and Bramham, C. R. (2007) Chronic fluoxetine treatment induces brain region-specific upregulation of genes associated with BDNF-induced long-term potentiation, Neural. Plast., 26496.
71. Consales, C., Volpicelli, F., Greco, D., Leone, L., Colucci-D'Amato, L., Perrone- Capano, C., and di Porzio, U. (2007) GDNF signaling in embryonic midbrain neurons in vitro, Brain Res., 1159, 28-39. (Pubitemid 47058026)
72. Dijkmans, T. F., van Hooijdonk, L. W., Schouten, T. G., Kamphorst, J. T., Fitzsimons, C. P., and Vreugdenhil, E. (2009) Identification of new nerve growth factor-responsive immediate-early genes, Brain Res., 1249, 19-33.
73. Alvarez-Rodriguez, R., Barzi, M., Berenguer, J., and Pons, S. (2007) Bone morphogenetic protein 2 opposes Shh-mediated proliferation in cerebellar granule cells through a TIEG-1-based regulation of Nmyc, J. Biol. Chem., 282, 37170-37180.
74. Gohla, G., Krieglstein, K., and Spittau, B. (2008) Tieg3/Klf11 induces apoptosis in OLI-neu cells and enhances the TGF-beta signaling pathway by transcriptional repression of Smad7, J. Cell Biochem., 104, 850-861. (Pubitemid 351830835)
75. Wahab, N. A., Weston, B. S., and Mason, R. M. (2005) Modulation of the TGFbeta/Smad signaling pathway in mesangial cells by CTGF/CCN2, Exp. Cell Res., 307, 305-314.
76. Coletta, D. K., Balas, B., Chavez, A. O., Baig, M., Abdul-Ghani, M., Kashyap, S. R., Folli, F., Tripathy, D., Mandarino, L. J., Cornell, J. E., Defronzo, R. A., and Jenkinson, C. P. (2008) Effect of acute physiological hyperinsulinemia on gene expression in human skeletal muscle in vivo, Am. J. Physiol., 294, E910-E917.
77. Hansen, L., Gaster, M., Oakeley, E. J., Brusgaard, K., Damsgaard Nielsen, E. M., Beck-Nielsen, H., Pedersen, O., and Hemmings, B. A. (2004) Expression profiling of insulin action in human myotubes: induction of inflammatory and pro-angiogenic pathways in relationship with glycogen synthesis and type 2 diabetes, Biochem. Biophys. Res. Commun., 323, 685-695. (Pubitemid 39221150)
78. Gutierrez-Aguilar, R., Benmezroua, Y., Balkau, B., Marre, M., Helbecque, N., Charpentier, G., Polychronakos, C., Sladek, R., Froguel, P., and Neve, B. (2007) Minor contribution of SMAD7 and KLF10 variants to genetic susceptibility of type 2 diabetes, Diabetes Metab., 33, 372-378.